Diabetes mellitus and hypertension are closely related, and guidelines have recommended aggressive treatment of hypertension in patients with diabetes. However, no single clinical trial is conclusive. An extensive review of the use of blood-pressure-lowering drugs in patients with diabetes supports treating blood pressure >140/90 mmHg, whereas reducing blood pressure in people with normal or high–normal blood pressure might have untoward effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Leren, P. et al. The Oslo Study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med. Scand. Suppl. 588, 1–38 (1975).
Hansson, L. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351, 1755–1762 (1998).
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Brit. Med. J. 317, 703–713 (1998).
ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370, 829–840 (2007).
The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575–1585 (2010).
Julius, S. et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363, 2022–2031 (2004).
Jamerson, K. et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 359, 2417–2478 (2008).
Brunström, M. & Carlberg, B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ 352, i717 (2016).
The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103–2116 (2015).
Kjeldsen, S. E., Narkiewicz, K., Hedner, T. & Mancia, G. The SPRINT study: outcome may be driven by difference in diuretic treatment de-masking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg. Blood Press. 25, 63–66 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.E.K. declares that he has received lecture and consulting honoraria from Bayer, Merck, and Takeda. I.O. declares no competing interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kjeldsen, S., Os, I. When should we treat hypertension in patients with diabetes?. Nat Rev Cardiol 13, 252–253 (2016). https://doi.org/10.1038/nrcardio.2016.49
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2016.49